Osteoporosis affects a disproportionately large number of Indian women, and the age at which bone loss becomes clinically significant is earlier in India than in most Western populations. The standard response in Indian clinical practice and in the supplement aisles of Indian pharmacies is calcium, often paired with vitamin D. This is appropriate guidance as far as it goes. Its limitation is that bone is not a simple calcium repository. It is a living, mineralised connective tissue that requires at least eight distinct minerals to build, maintain, and repair itself at full capacity.

She-Lajit delivers shilajit's 85+ ionic trace minerals through fulvic acid alongside shatavari's phytoestrogenic support, addressing the complete mineral and hormonal requirements of bone health in Indian women. The calcium conversation is a necessary beginning. Here is what comes after it.

Why Indian women face a specific bone health challenge

India's osteoporosis burden is significant, and its characteristics differ from Western populations in ways that make the trace mineral gap particularly consequential. Indian women develop clinically significant bone loss at younger ages and lower body weights than Western women of comparable age. The combination of genetic bone architecture, early menopause in some populations, chronic vitamin D deficiency from indoor lifestyles despite abundant sunlight, and the mineral absorption challenges of the Indian vegetarian diet creates a bone health vulnerability that a calcium supplement alone does not adequately address.

Ayurveda recognised the complexity of asthi, the bone dhatu, as a tissue requiring nourishment from multiple sources through the dhatu formation chain. The Charaka Samhita prescribed asthi-vardhaka, bone-nourishing formulations, that went well beyond single-ingredient approaches. The classical understanding that bone health requires comprehensive nutritional support, not a single supplement, was an empirically accurate observation that modern bone biology has since explained at the molecular level.

Magnesium: why Indian women's diets deliver less than they appear to

Magnesium appears to be adequately supplied by the Indian diet. Dal, green leafy vegetables, nuts, and seeds all contain meaningful magnesium quantities. The problem is that these same foods contain phytic acid, and phytate binds magnesium in the digestive tract, significantly reducing the proportion that is actually absorbed.

This phytate-magnesium binding means that Indian women consuming apparently adequate dietary magnesium may have functional magnesium deficiency at the cellular level. And the consequences for bone are threefold.

First, approximately 60 percent of the body's magnesium is stored in bone. When cellular magnesium is chronically insufficient, bone magnesium is drawn upon to maintain blood levels, progressively depleting bone mineral content in a process that standard blood tests do not detect because serum magnesium remains normal at the expense of bone stores.

Second, osteoblasts, the bone-forming cells that build the collagen matrix and initiate its mineralisation, require intracellular magnesium for their function. Reduced osteoblast activity means slower bone formation in the remodelling cycle.

Third, the enzyme that converts vitamin D to its active form in the kidney requires magnesium as a cofactor. Indian women supplementing vitamin D for bone health without adequate magnesium are producing inactive circulating vitamin D rather than the active form that drives intestinal calcium absorption. The calcium and vitamin D strategy fails at the absorption stage when magnesium is deficient.

Zinc and why India's dietary pattern creates specific bone mineralisation risk

India has among the world's highest rates of zinc deficiency, driven by the phytate content of the predominantly grain and legume-based Indian diet. The phytate-zinc binding that reduces magnesium absorption applies equally to zinc, making dietary zinc intake a systematically unreliable indicator of actual zinc status in Indian women.

Alkaline phosphatase, the enzyme that mineralises the collagen matrix of bone by precipitating hydroxyapatite crystals, is zinc-dependent. Without adequate intracellular zinc, this mineralisation enzyme operates below capacity regardless of how much calcium is circulating. This is why Indian women with high calcium intake may still show suboptimal bone mineralisation: the enzyme that deposits calcium into bone requires zinc that their dietary pattern chronically under supplies.

Zinc also supports the cellular balance of bone remodelling by stimulating osteoblast bone formation and inhibiting osteoclast bone resorption. This dual action on both sides of the bone turnover equation makes zinc a mineral whose deficiency accelerates bone loss from both directions simultaneously.

Copper and the structural strength that mineral density measurements miss

Bone density, measured by the DXA scans that Indian orthopaedic clinics are increasingly offering, reflects mineral content per unit of bone volume. This is a meaningful measurement but an incomplete one. Structural bone strength, the resistance to fracture under the forces of falls and impact, depends equally on the mechanical integrity of the collagen matrix.

Collagen fibres in bone are structurally reinforced through cross-links formed by lysyl oxidase, a copper-dependent enzyme. These cross-links give bone its tensile strength. Without adequate copper, collagen cross-linking is reduced, producing bone that can have normal density measurements but fractures more readily under mechanical load. Indian women whose clinical bone health assessment finds normal or near-normal density but who still sustain fractures from modest falls may have a copper-related collagen cross-linking deficit alongside or instead of a mineralisation deficit.

Silicon, manganese, boron, and why Indian women in perimenopause need them specifically

Silicon stimulates collagen synthesis, the production of the organic matrix framework into which all bone mineral is deposited. Bone is approximately 35 percent collagen by dry weight, and silicon's role in collagen production makes it a foundational mineral for bone matrix formation. Manganese is a cofactor for the enzymes producing the proteoglycans that fill the collagen matrix and contribute to bone's mechanical behaviour.

Boron supports calcium and magnesium retention and is associated with oestrogen metabolism. This makes it particularly relevant to Indian women approaching perimenopause. Oestrogen supports osteoblast bone formation and inhibits osteoclast bone resorption. Its decline during perimenopause accelerates bone loss from both cellular directions simultaneously.

She-Lajit's shatavari component contains phytoestrogenic steroidal saponins associated with oestrogen receptor support. Combined with shilajit's complete trace mineral spectrum, this addresses both the hormonal dimension of perimenopausal bone loss and the mineral cofactor requirements of bone formation simultaneously.

Our She-Lajit Honey Sticks deliver shilajit's 85+ ionic minerals through fulvic acid alongside shatavari and saffron in raw Himalayan honey. FSSAI-compliant. GMP-certified. Third-party tested on every batch.

Conclusion

India's osteoporosis burden requires an approach to women's bone health that goes beyond the calcium and vitamin D guidance that has been the standard recommendation. Bone formation, mineralisation, matrix cross-linking, and remodelling all require minerals that Indian women's dietary patterns consistently undersupply through the phytate-driven absorption inhibition that affects magnesium, zinc, and every other mineral simultaneously. She-Lajit's 85+ ionic trace minerals, delivered through fulvic acid to the intracellular environment where osteoblasts perform their bone-building work, addresses the complete mineral requirement. The asthi-vardhaka principle the Charaka Samhita described was always about comprehensive nutritional support. Modern bone biology explains why that was the correct approach.